Francis Blankenberg

Publication Details

• The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection.

  Vriens PW, Blankenberg FG, Stoot JH, Ohtsuki K, Berry GJ, Tait JF, Strauss HW, Robbins RC. J Thorac Cardiovasc Surg. 1998; 116 (5): 844-53

  Apoptosis, or programmed cell death, has been suggested as a mechanism of immunologic injury during cardiac allograft rejection. We tested the hypothesis that technetium Tc 99m annexin V, a novel radiopharmaceutical used to detect apoptosis, can be used to detect cardiac allograft rejection by nuclear imaging.

  PubMedID: 9806391